DETECT-ME/CFS project

by DETECT-ME/CFS project (ME/CFS Research Foundation)  · Based in Germany → — AI-supported diagnostics for ME/CFS to improve diagnostic processes and resource utilisation in healthcare.
Internal Medicine Neurology Rheumatology

Documentation Provided

Overview

The DETECT-ME/CFS project is an initiative focused on developing an innovative clinical decision support system (CDSS) to enhance the diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). This project aims to address the challenges of limited resources and high workload in specialized facilities by leveraging artificial intelligence (AI) to support clinical expertise and decision-making processes.

The CDSS is designed to improve diagnostic accuracy and efficiency through a dual approach. Firstly, it will analyze anonymized patient data to identify patterns and novel diagnostic features, enabling more reliable exclusion of differential diagnoses. Secondly, the system will incorporate an automated literature search mechanism for ME/CFS and established differential diagnoses, utilizing machine learning to bolster overall diagnostic capabilities.

Currently in development, the CDSS will undergo testing in practical clinical settings. It features automated closed-loop learning mechanisms for continuous improvement, ensuring its adaptability and evolving effectiveness. The long-term vision for this model extends beyond ME/CFS, with potential applicability for the clinical diagnosis of other complex diseases, representing a significant advancement in healthcare.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-supported clinical decision support system (CDSS)
  • Analysis of anonymized patient data for diagnostic patterns
  • Identification of new diagnostic features
  • Reliable exclusion of differential diagnoses
  • Automated literature search for ME/CFS and differential diagnoses
  • Machine learning for improved diagnostic capabilities
  • Automated closed-loop learning for continuous improvement
  • Potential for diagnosis of other complex diseases

Use Cases

  • Rapid and reliable diagnosis of ME/CFS
  • Improving diagnostic accuracy in specialized facilities
  • Enhancing efficiency in healthcare resource utilization
  • Supporting clinical expertise in complex disease diagnosis
  • Identifying novel diagnostic biomarkers
  • Automating literature review for diagnostic purposes

What Physicians Need to Know

Project Goal
The DETECT-ME/CFS project aims to improve the screening and diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) to reduce the burden on specialized clinics and enable timely patient care.
Evidence Base
The system integrates clinical expertise and diagnostic decision-making processes into computer-based algorithms. It will also incorporate a symptom-disease association model based on automated literature mining of ME/CFS and related differential diagnoses. The project aims to identify patterns and novel diagnostic features through AI-based analyses of patient databases.
Clinical Validation Studies
The system will undergo a multi-phase real-world evaluation. Several ongoing research initiatives are focused on developing and validating diagnostic biomarkers for ME/CFS, including blood-based tests with reported sensitivities of 92% and specificities of 98% in independent validation cohorts. Other studies are exploring cell-free RNA analysis with 77% accuracy and AI models achieving 98% accuracy in predicting ME/CFS.
Differential Diagnosis Support
The CDSS will support the differentiation and exclusion of differential diagnoses for ME/CFS. ME/CFS symptoms can mimic those of many other conditions, such as sleep disorders, other medical conditions (e.g., anemia, diabetes, thyroid issues), and mental health conditions (e.g., depression, anxiety). The system will aim to identify patterns and novel diagnostic features to support the differentiation and exclusion of these.
Guideline Update Frequency
The system incorporates closed-loop learning mechanisms for continuous optimization, suggesting an adaptive and frequently updated approach to guidelines and diagnostic features. There is ongoing research to reach a consensus on ME/CFS research criteria, which could influence future guideline updates.
Clinical Workflow Integration
The project aims to develop an innovative Clinical Decision Support System (CDSS) that integrates clinical expertise and diagnostic decision-making processes into computer-based algorithms, suggesting direct integration into clinical workflows.
Decision Audit Trail
While not explicitly detailed for DETECT-ME/CFS, clinical decision support systems in general utilize audit trails to log changes and actions related to clinical data, capturing who accessed the system, when data was entered or changed, and why. Generative AI can be instrumental in extracting insights from audit data in clinical trials.
Physician Tip

The DETECT-ME/CFS CDSS is designed to aid in the complex diagnosis of ME/CFS by integrating clinical expertise with AI-driven analysis of patient data and literature. Pay close attention to the system's differential diagnosis support, as ME/CFS shares symptoms with numerous other conditions. Be aware that patients with ME/CFS can be particularly sensitive to medications, often requiring lower-than-standard doses. The system's continuous learning mechanisms mean that its recommendations will evolve, so staying updated with its outputs will be crucial for optimal use. Early intervention in ME/CFS is linked to better long-term outcomes.

The DETECT-ME/CFS project is developing a standalone CDSS. However, other initiatives like 'Solve Together' are creating patient-centered platforms that integrate multiple data sources, including health-tracking wearables, and aim to make data accessible to researchers. Future integrations could involve linking with such platforms or electronic health records (EHRs) to leverage real-time patient data for enhanced diagnostic accuracy and personalized management strategies. The use of AI and machine learning in this project suggests potential for integration with other AI-powered diagnostic and research tools.

Details

Category Clinical Decision Support & Reference, Neurology AI
Pricing Unknown
Mobile AppThe project is developing a Clinical Decision Support System (CDSS) that supports clinical expertise and decision-making processes with the help of artificial intelligence. While not explicitly stated as a mobile app, other ME/CFS research projects and patient management tools often involve mobile applications for data collection and symptom tracking.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Unknown
Integrations
EHR Not specified
Specialties Internal Medicine, Neurology, Rheumatology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate DETECT-ME/CFS project

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for DETECT-ME/CFS project.

Loading videos...

View all on YouTube

Frequently Asked Questions

The DETECT-ME/CFS project is developing a clinical decision support (CDS) tool designed to assist physicians in the diagnosis and management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). It aims to provide evidence-based guidance, streamline diagnostic pathways, and suggest appropriate management strategies, thereby enhancing diagnostic accuracy and improving patient outcomes for this complex condition.
The DETECT-ME/CFS CDS tool is being developed with interoperability in mind, aiming for seamless integration with common EHR systems through standard APIs. The goal is to minimize disruption to existing workflows by providing alerts and recommendations within the physician's usual interface, rather than requiring a separate application. Specific integration details and workflow impacts will be provided upon the tool's release.
Details regarding the pricing structure for the DETECT-ME/CFS CDS tool are still under development. The project aims to make the tool accessible to a wide range of clinical practices, and various models, including subscription-based or tiered pricing, are being considered. Information on costs and licensing will be made available closer to the official launch.
While the DETECT-ME/CFS CDS tool will be built on current evidence, it's important to acknowledge that the understanding of ME/CFS is continually evolving. The tool's primary limitations may include its reliance on available data and the inherent complexities of diagnosing a multi-system illness. The project plans for regular updates to incorporate new research and clinical guidelines, ensuring the tool remains current and relevant.
Currently, there are limited comprehensive, evidence-based clinical decision support tools specifically for ME/CFS. DETECT-ME/CFS aims to differentiate itself by offering a robust, integrated platform that incorporates the latest diagnostic criteria, symptom assessment, and management recommendations, developed through a collaborative, multidisciplinary approach. It seeks to fill a significant gap in current clinical practice for this patient population.
Comprehensive training materials, including webinars, user manuals, and online tutorials, will be developed to guide physicians in the effective and compliant use of the DETECT-ME/CFS CDS tool. Ongoing technical support and a dedicated help desk will also be available to address any questions or issues that may arise during its implementation and use in clinical practice.
The DETECT-ME/CFS project prioritizes data privacy and security, adhering to all relevant healthcare regulations such as HIPAA and GDPR. The CDS tool will be designed with robust security protocols, including encryption and access controls, to protect patient health information. Data integration will follow secure, standardized methods, ensuring that patient data remains confidential and is used solely for its intended clinical decision support purpose.

Related Tools

Stanford University
Stanford University
Clinical Decision Support & Reference
Stanford Online's "AI in Healthcare" program provides a comprehensive overview of artificial intelligence's applications and implications within the medical field.
RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
Med-PaLM 2
Google
Clinical Decision Support & Reference
Med-PaLM 2 is a large language model from Google, fine-tuned for healthcare to provide high-quality answers to medical questions and support clinical decision-making.
Pacmed Critical Discharge
Pacmed
Clinical Decision Support & Reference
Pacmed Critical Discharge is an AI tool that predicts the probability of death or readmission within seven days of ICU discharge, providing explainable insights for physicians.
AiZtech Labs
AiZtech Labs
Clinical Decision Support & Reference
AiZtech Labs provides enterprise-grade AI solutions for healthcare, focusing on operational efficiency, diagnostic accuracy, and patient care workflows for providers and health systems.
Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-09-11 | First Added: 2026-09-11
AI Tool Finder
AI-powered search. Results may not be comprehensive.